saxenda
Liraglutide · by Novo Nordisk Inc
Not yet rated· sourced from the FDA label · how we rate
Verified againstopenFDANIH DailyMedRxClass
Overview
Saxenda (Liraglutide) is a glp-1 receptor agonist used to treat Obesity, Overweight.
From the FDA label:Saxenda (liraglutide) is a once-daily GLP-1 receptor agonist injection approved for chronic weight management in adults with obesity (or overweight with a weight-related medical problem) and in adolescents aged 12 and older with obesity, used together with a reduced-calorie diet and increased physical activity.
Drug class
May treat
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Saxenda treat?
- Saxenda (Liraglutide) is indicated for obesity, overweight, per its drug-label indications. This is general reference, not medical advice.
- Who makes Saxenda?
- Saxenda is marketed by Novo Nordisk Inc. You can see Novo Nordisk Inc's full profile, rating, and other products on pharmaranks.
- Is Saxenda a brand-name or generic drug?
- Saxenda is a brand-name product with the active ingredient Liraglutide. Lower-cost generic equivalents containing Liraglutide may also be available.
- What class of drug is Saxenda?
- Saxenda is classified as glp-1 receptor agonist, per the FDA's Established Pharmacologic Class.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Saxenda head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
saxenda
New